1CP
HQL
1607 Capital Partners’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Sell |
161,971
-19,000
| -10% | -$243K | 0.17% | 92 |
|
|
2025
Q1 | $2.3M | Sell |
180,971
-66,176
| -27% | -$840K | 0.19% | 82 |
|
|
2024
Q4 | $3.24M | Sell |
247,147
-102,354
| -29% | -$1.34M | 0.26% | 79 |
|
|
2024
Q3 | $5.27M | Sell |
349,501
-69,778
| -17% | -$1.05M | 0.48% | 59 |
|
|
2024
Q2 | $5.94M | Sell |
419,279
-62,100
| -13% | -$880K | 0.53% | 56 |
|
|
2024
Q1 | $6.56M | Buy |
481,379
+1,200
| +0.2% | +$16.4K | 0.54% | 55 |
|
|
2023
Q4 | $6.46M | Buy |
480,179
+764
| +0.2% | +$10.3K | 0.45% | 65 |
|
|
2023
Q3 | $5.98M | Hold |
479,415
| – | – | 0.45% | 61 |
|
|
2023
Q2 | $6.49M | Buy |
479,415
+15,700
| +3% | +$213K | 0.47% | 59 |
|
|
2023
Q1 | $6.46M | Buy |
463,715
+73,984
| +19% | +$1.03M | 0.45% | 61 |
|
|
2022
Q4 | $5.54M | Buy |
389,731
+304,830
| +359% | +$4.33M | 0.38% | 69 |
|
|
2022
Q3 | $1.16M | Buy |
+84,901
| New | +$1.16M | 0.09% | 115 |
|
|
2021
Q4 | – | Sell |
-10,000
| Closed | -$208K | – | 116 |
|
|
2021
Q3 | $208K | Sell |
10,000
-100,901
| -91% | -$2.1M | 0.01% | 105 |
|
|
2021
Q2 | $2.38M | Sell |
110,901
-48,842
| -31% | -$1.05M | 0.11% | 87 |
|
|
2021
Q1 | $3.15M | Sell |
159,743
-43,245
| -21% | -$852K | 0.15% | 93 |
|
|
2020
Q4 | $4.01M | Hold |
202,988
| – | – | 0.2% | 78 |
|
|
2020
Q3 | $3.57M | Buy |
202,988
+27,964
| +16% | +$492K | 0.19% | 82 |
|
|
2020
Q2 | $3.14M | Buy |
175,024
+101,513
| +138% | +$1.82M | 0.17% | 84 |
|
|
2020
Q1 | $1.1M | Buy |
+73,511
| New | +$1.1M | 0.07% | 113 |
|